Jul 30, 2002

Davis Wright Tremaine

Davis Wright Tremaine named Bill Sherman an associate in its Seattle office. Sherman will join the firm's litigation department. He was previously a law clerk for Judge M. Margaret McKeown and Judge John C. Coughenour. Also, LaVerne Woods, a partner in the firm, has been chosen to join the American Law Institute. The national organization is by membership only and is based on achievement and recommendation from current members.

Bratrud Middleton Insurance

Walter L. Harrison was appointed a vice president at Bratrud Middleton Insurance.He will head the financial services division and oversee staff members in the Tacoma and Longview offices. Harrison has been with the Tacoma-based agency since 1985.

Microsoft

Microsoft named John Walthall director of worldwide sales for its Microsoft TV Division. Walthall was previously vice president, sales for the Americas at Liberate Technologies. Walthall will work with multiple service operators around the globe to deploy interactive TV services based on the Microsoft TV platform. Microsoft also named Kirill Tatarinov as corporate vice president of its management business group. He will lead development and marketing efforts for Microsoft Windows management solutions. Tatrinov was previously with BMC Software as senior vice president and chief technology officer.

Nordstrom

Jim Bromley is the new president of Nordstrom's catalog and Internet division. Bromley was most recently the division's executive vice president and chief financial officer. The company is changing the name of the division formerly known as Nordstrom.com to Nordstrom Direct and it will become a wholly owned subsidiary. Nordstrom Direct will manage the company's e-commerce site, Nordstrom.com and its two direct mail catalogs.

Kibble & Prentice

Kibble & Prentice acquired Rourke & Bell, a Pacific Northwest personal and business insurance brokerage. Employees of Rourke & Bell will join Kibble & Prentice's Bellevue office. The firm gains additional expertise in the construction insurance and medical malpractice fields through this acquisition.

Jul 29, 2002

The Harris

The Harris named Peter D. Glidden market president in its Bellevue office and Valerie M. Kampe vice president and senior portfolio manager in its Seattle area. Glidden will continue as head of investments in Washington for the firm; he joined The Harris in April by acquiring Northwestern Trust. Kampe most recently served as chief financial officer at Rhodes, Ragen & Smith in Seattle. The Harris is a trade named used by a group of U.S. financial service providers as part of the Bank of Montreal.

Seattle V.I.P Services

Darci Russell is the new president at Seattle V.I.P Services. She previously served as Seattle V.I.P.'s vice president and general manager. Seattle V.I.P Services is a full service local destination and event management company which was recently purchased by Seattle Hospitality Group.

Group Health

Paul Sherman, M.D. has been named medical director for Group Health's Consultative Specialty Services. Sherman, along with administrative partner Carla Bush, will lead over 1,000 of Group Health's medical and surgical specialists. Sherman was previously medical director for Group Health's Seattle District.

Xyron Semiconductor

David Perry joined Xyron Semiconductor as vice president of marketing. Perry recently worked with Zayante and Leopard Logic, and is the cofounder of S-Mos Systems. Xyron, based in Vancouver markets its patented Zots circuitry, which manages system interrupt handling and task management in microprocessors.

Genemax

Genemax Corp., as part of restructuring following the reverse takeover of GeneMax Pharmaceuticals, named Dr. Julia Levy chairman of the board of directors. Levy is joined by Ron Handford, Dr. Wilf Jefferies, James Davidson, Dr. Calvin Stiller, Alan Linday, and Grant Atkins as directors. Handford will serve as president and CEO, Davidson will serve as chief financial officer and secretary, and Jefferies will serve as chief scientist officer. GeneMax, based in Blaine, is a biotech company specializing in the treatment of cancer, and therapies for infectious diseases, autoimmune disorders and transplant tissue rejection.